SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.580-3.0%9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bobbseytwins2001 who wrote (1201)10/23/2025 12:17:14 PM
From: dorightbythem1 Recommendation

Recommended By
erippetoe

  Read Replies (1) of 1216
 
Twins I don’t dispute that there are trials, in fact I prefer more trials that deal with PSS’s latest assertions about arming our own immune systems. I would like to see more, clarity and information on overseas approvals and sales. Unfortunately, those updates are few and far between.
Another point I fell short of discussing is that there will be no stockholder revolt this time due to an imbalance of shareholder ownership. Furthermore, the balance sheet, lack of funds and slow ramp up of sales leave the company exposed to the shorts. A well warned tale.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News